EyePoint Pharmaceuticals, Inc. — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2020-02-28

Reporting Person: Jones David Scott (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-28	Restricted Stock Units	$0.00	A	123150.00	Acquired		Common Stock (123150.00)	Direct
2020-02-28	Stock Option (Right to Buy)	$1.29	A	246250.00	Acquired	2030-02-28	Common Stock (246250.00)	Direct

Footnotes

F1: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022.

F2: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which begin March 28, 2020